白血球除去療法の世界市場

白血球除去療法の世界市場は2030年までに1億4,370万米ドルに達する見込み

2023年に8,970万米ドルと推定された白血球除去療法の世界市場は、2030年には1億4,370万米ドルに達し、分析期間2023-2030年のCAGRは7.0%で成長すると予測されます。白血球除去療法デバイスは、本レポートで分析したセグメントの1つであり、CAGRは7.1％を記録し、分析期間終了時には1億2,260万米ドルに達すると予測されています。白血球除去療法ディスポーザブル・セグメントの成長率は、分析期間中CAGR 6.0％と推定されます。

米国市場は2,460万米ドル、中国はCAGR 6.5％で成長すると予測

米国の白血球除去療法市場は、2023年に2,460万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2,220万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.7％と5.6％と予測されています。欧州では、ドイツがCAGR 5.8%で成長すると予測されています。

世界の白血球除去療法市場- 主要動向と促進要因まとめ

白血球除去療法とは何か、なぜ治療において重要性を増しているのか？

白血球除去療法は、血液中の白血球（白血球）を選択的に除去する医療処置であり、白血病、多発性骨髄腫、自己免疫疾患など、様々な疾患の治療に用いられるようになってきています。白血病、多発性骨髄腫、自己免疫疾患など、さまざまな疾患の治療に用いられることが多くなっています。この方法は、治療と研究の両方の場面で重要な役割を果たすため、重要性を増しています。治療的応用では、白血球除去療法は、ある種のがん患者において危険な白血球数の増加を抑えるために使用されます。研究においては、CAR-T細胞療法などの新しい治療法の開発・試験に使用する白血球を採取するために使用されます。高度な治療オプションへの需要が高まるにつれ、白血球除去療法は医療分野で不可欠なツールになりつつあります。

技術の進歩は白血球除去療法市場にどのような影響を与えていますか？

技術の進歩は、白血球除去療法市場の成長に重要な役割を果たしています。より効率的で自動化されたアフェレーシス装置の開発により、患者にとってより安全で、より迅速で、より快適な処置が可能となった。これらの進歩はまた、CAR-T細胞療法のような治療の成功に特に重要な白血球の高い収率を可能にしています。さらに、白血球除去療法の技術革新は合併症のリスクを減らし、患者の転帰を改善しています。技術が進化し続けるにつれて、白血球除去療法の有効性とアクセシビリティがさらに向上し、臨床と研究の両方の場面で採用されることが期待されます。

白血球除去療法ががん治療の進歩に果たす役割とは？

白血球除去療法は、がん治療の進歩、特にCAR-T細胞療法などの免疫療法の開発において重要な役割を果たしています。この治療法では、白血球除去療法を使って患者の血液からT細胞を採取し、がん細胞を標的にして破壊するように遺伝子組み換えを行います。がん治療に対するこの個別化アプローチは、特にある種の白血病やリンパ腫の患者において有望な結果を示しています。このような治療法の成功が増加しているため、治療プロセスにおいて重要なステップである白血球除去療法の需要が高まっています。より多くの免疫療法が開発・承認されるにつれて、白血球除去療法の使用は拡大し、がん治療の将来における重要な要素になると予想されます。

白血球除去療法市場の成長を促進する要因とは？

白血球除去療法市場の成長は、がんや自己免疫疾患の有病率の増加、アフェレシス技術の進歩、個別化医療に対する需要の高まりなど、いくつかの要因によってもたらされます。また、免疫細胞の収集に白血球除去療法を利用する免疫療法の採用が増加していることも大きな推進力となっています。さらに、新しい治療法の開発に焦点を当てた臨床試験や研究活動の拡大が、白血球除去療法処置の需要を押し上げています。医療界が新たな治療法の模索や既存の治療法の改良を続ける中、白血球除去療法市場は、現代医療の進歩に重要な役割を果たすことから、持続的な成長が見込まれています。

調査対象企業の例（全12件）

• Allcells LLC
• Asahi Kasei Medical Co., Ltd.
• BioIVT
• Caltag Medsystems Limited
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• HemaCare Corporation
• Key Biologics, LLC.
• MacoPharma SA
• Ppa Research Group, Inc.
• Precision Medicine Group, Inc.
• StemCell Technologies Inc.
• StemExpress
• Terumo BCT, Inc.
• Zenbio, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• その他の地域

第4章 競合

Global Leukapheresis Market to Reach US$143.7 Million by 2030

The global market for Leukapheresis estimated at US$89.7 Million in the year 2023, is expected to reach US$143.7 Million by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Leukapheresis Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$122.6 Million by the end of the analysis period. Growth in the Leukapheresis Disposables segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.6 Million While China is Forecast to Grow at 6.5% CAGR

The Leukapheresis market in the U.S. is estimated at US$24.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$22.2 Million by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Leukapheresis Market - Key Trends & Drivers Summarized

What Is Leukapheresis and Why Is It Gaining Importance in Medical Treatments?

Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from the blood, which is increasingly being used in the treatment of various diseases, including leukemia, multiple myeloma, and autoimmune disorders. This procedure is gaining importance due to its critical role in both therapeutic and research settings. In therapeutic applications, leukapheresis is used to reduce high white blood cell counts, which can be dangerous in certain cancer patients. In research, it is employed to collect leukocytes for use in developing and testing new therapies, such as CAR-T cell therapy. As the demand for advanced treatment options grows, leukapheresis is becoming an essential tool in the medical field.

How Are Technological Advancements Impacting the Leukapheresis Market?

Technological advancements are playing a significant role in the growth of the leukapheresis market. The development of more efficient and automated apheresis machines has made the procedure safer, faster, and more comfortable for patients. These advancements are also enabling higher yields of leukocytes, which is particularly important for the success of therapies like CAR-T cell therapy. Additionally, innovations in leukapheresis techniques are reducing the risk of complications and improving patient outcomes. As technology continues to evolve, it is expected to further enhance the efficacy and accessibility of leukapheresis, driving its adoption in both clinical and research settings.

What Role Does Leukapheresis Play in the Advancement of Cancer Therapies?

Leukapheresis is playing a crucial role in the advancement of cancer therapies, particularly in the development of immunotherapies such as CAR-T cell therapy. In this process, leukapheresis is used to collect T cells from the patient’s blood, which are then genetically modified to target and destroy cancer cells. This personalized approach to cancer treatment has shown promising results, especially in patients with certain types of leukemia and lymphoma. The increasing success of these therapies is driving demand for leukapheresis, as it is a critical step in the treatment process. As more immunotherapies are developed and approved, the use of leukapheresis is expected to expand, making it a key component in the future of cancer treatment.

What Factors Are Driving the Growth of the Leukapheresis Market?

The growth in the leukapheresis market is driven by several factors, including the increasing prevalence of cancer and autoimmune diseases, advancements in apheresis technology, and the rising demand for personalized medicine. The growing adoption of immunotherapies, which rely on leukapheresis for the collection of immune cells, is also a significant driver. Additionally, the expansion of clinical trials and research activities focused on developing new treatments is boosting the demand for leukapheresis procedures. As the medical community continues to explore new therapeutic applications and improve existing ones, the leukapheresis market is expected to experience sustained growth, driven by its critical role in advancing modern medical treatments.

Select Competitors (Total 12 Featured) -

• Allcells LLC
• Asahi Kasei Medical Co., Ltd.
• BioIVT
• Caltag Medsystems Limited
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• HemaCare Corporation
• Key Biologics, LLC.
• MacoPharma SA
• Ppa Research Group, Inc.
• Precision Medicine Group, Inc.
• StemCell Technologies Inc.
• StemExpress
• Terumo BCT, Inc.
• Zenbio, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Leukapheresis - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advancements in Apheresis Technology Propel Adoption of Leukapheresis in Therapeutic Applications
  • Shift Towards Personalized Medicine Expands Addressable Market for Leukapheresis
  • Rising Focus on Cell-Based Therapies and Immunotherapy Drives Adoption in Cancer Treatment
  • Rising Importance of Leukapheresis in Bone Marrow Transplantation Strengthens Demand
  • Growing Application of Leukapheresis in Stem Cell Collection Strengthens Market Demand
  • Technological Innovations in Leukapheresis Devices Enhance Efficiency and Patient Comfort
  • Expanding Use of Leukapheresis in Hematology and Oncology Generates New Opportunities
  • Push for High-Purity Cell Collection Fuels Demand in Clinical and Research Settings
  • Increasing Adoption of Leukapheresis in CAR-T Cell Therapy Accelerates Market Expansion
  • Technological Advancements in Automated and Continuous Flow Systems Expand Market Potential
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Blood Component Providers & Blood Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Blood Component Providers & Blood Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Leukapheresis Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Leukapheresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospital & Transfusion Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Hospital & Transfusion Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• JAPAN
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• CHINA
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 58: China 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 61: China 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• EUROPE
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Leukapheresis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Leukapheresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• FRANCE
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 79: France 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 82: France 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 85: France 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• GERMANY
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 115: Rest of Europe 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 117: Rest of Europe Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 118: Rest of Europe 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Rest of Europe Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 121: Rest of Europe 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Leukapheresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 124: Asia-Pacific 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 127: Asia-Pacific 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Asia-Pacific Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 130: Asia-Pacific 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Application - Research and Therapeutic - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Rest of World Historic Review for Leukapheresis by Application - Research and Therapeutic Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 133: Rest of World 16-Year Perspective for Leukapheresis by Application - Percentage Breakdown of Value Sales for Research and Therapeutic for the Years 2014, 2024 & 2030
  • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Rest of World Historic Review for Leukapheresis by End-Use - Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 136: Rest of World 16-Year Perspective for Leukapheresis by End-Use - Percentage Breakdown of Value Sales for Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharma & Biotech Companies and Hospital & Transfusion Centers for the Years 2014, 2024 & 2030
  • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Leukapheresis by Offering - Devices and Disposables - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of World Historic Review for Leukapheresis by Offering - Devices and Disposables Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of World 16-Year Perspective for Leukapheresis by Offering - Percentage Breakdown of Value Sales for Devices and Disposables for the Years 2014, 2024 & 2030

IV. COMPETITION